Single-Use Bioprocessing Market Size 2022 To 2030
Single-Use Bioprocessing Market Insights The global single-use bioprocessing market size accounted for US$ 25.44 billion in 2022 and is expected to hit US$ 84.12 billion …
To give accurate information is our responsibly.
Single-Use Bioprocessing Market Insights The global single-use bioprocessing market size accounted for US$ 25.44 billion in 2022 and is expected to hit US$ 84.12 billion …
According to Precedence Research, the global home healthcare market size accounted for USD 299.24 billion in 2021, which grew to USD 332.86 billion in 2022 …
Get Sample ReportView Full ReportRequest Customization Biosensors are widely utilized in the healthcare industry for sensing, identifying, and monitoring a variety of human illnesses. The …
Integration of artificial intelligence (AI) is picking up pace in drug development. AI is used for various aspects, starting from the discovery of compounds exhibiting …
Ovarian cancer research and development (R&D) is gathering steam worldwide. Companies operating in the space have upped their R&D spending on vaccine development and other …
Plug and play platforms are common knowledge, especially across retail, shopping, transportation, accommodation, and other sectors. Healthcare in India is gearing to join the bandwagon, …
Exponential surge in telehealth post-COVID-19 is among the primary breakthroughs registered during the pandemic. House calls became a common practice and continue to persist as …
Butterfly Network, Inc., a globally renowned digital innovator has collaborated with Petco Health and Wellness Company, Inc., to integrate the latter’s expanding network of nearly …
As the healthcare sector gears for digital transformation, machine learning, robotic process automation, natural language processing, predictive analysis, and cognitive process automation are among the …
AstraZeneca has identified an additional novel target for its drug development portfolio for idiopathic pulmonary fibrosis (IPF), allowing BenevolentAI, a leading clinical-stage AI-enabled drug discovery …